Press release
Impact Of The Growing Geriatric Population On Healthcare Demands: A Significant Driver Propelling The Renal Cell Carcinoma Market In 2025
Renal Cell Carcinoma
What Is the Renal Cell Carcinoma Market Size and Projected Growth Rate?
The market for renal cell carcinoma has witnessed robust expansion in the last few years. The market is predicted to increase from $0.69 billion in 2024 to $0.74 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.0%. This surge during the historic period can be ascribed to factors such as a higher prevalence of kidney cancer, a growing aging population, a rise in the adoption of targeted therapy approaches, increased consciousness around cancer screenings, enhanced healthcare systems, and an escalation in investment towards oncology research and development.
In the upcoming years, the renal cell carcinoma market size is projected to witness robust growth, expanding to $0.95 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth in the forecast period is primarily due to the increasing acceptance of personalized medicine, escalating consciousness about early cancer diagnosis, increasing investment in oncology by healthcare sector, enhanced healthcare accessibility, and ongoing clinical trials and research on innovative therapies. Major trends expected during this period involve the incorporation of AI for precision diagnosis, the creation of targeted therapies, breakthroughs in immunotherapy, progression in biomarker discovery, embrace of minimally invasive surgical techniques, and advancements in imaging technologies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20944
What Are the Major Segments in the Renal Cell Carcinoma Market?
The renal cell carcinoma market covered in this report is segmented -
1) By Type: Clear Cell Renal Cell Carcinoma (RCC), Papillary Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma (RCC)
2) By Diagnosis: Urine Tests, Computed Tomography (CT) Scan, Nephrectomy, Blood Tests, Ultrasound, Biopsy
3) By Treatment: Medication, Ablation, Targeted Therapy, Chemotherapy, Surgery, Other Treatments
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Clear Cell Renal Cell Carcinoma (RCC): Sporadic Clear Cell RCC, Hereditary Clear Cell RCC
2) By Papillary Renal Cell Carcinoma (RCC): Type 1 Papillary RCC, Type 2 Papillary RCC
3) By Chromophobe Renal Cell Carcinoma (RCC): Classic Chromophobe RCC, Hybrid Chromophobe RCC
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20944&type=smp
What Are The Driving Renal Cell Carcinoma Market Evolution?
The escalating number of older adults is anticipated to propel the expansion of the renal cell carcinoma market in the future. The senior population, typically those aged 65 and over, often have specific health and social needs. The surge in this demographic is propelled by advancements in healthcare, improved nutrition, and extended life expectancies. Renal cell carcinoma (RCC) has a heightened prevalence among senior individuals, emphasizing the necessity for age-specific screening and treatment plans. For instance, a study released by the Population Reference Bureau, a non-profit organization in the US accountable for gathering statistics for research and educational uses, predicted in January 2024 that the count of Americans aged 65 and over is envisaged to escalate from 58 million in 2022 to 82 million by 2050; this represents a 47% increase. Hence, the escalation in the senior population is stimulating the expansion of the renal cell carcinoma market.
Which Firms Dominate The Renal Cell Carcinoma Market Segments?
Major companies operating in the renal cell carcinoma market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Fresenius Kabi AG, GSK plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc. (Mylan N.V.), Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Cipla Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Exelixis Inc., Nektar Therapeutics
What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leading firms in the renal cell carcinoma sector are concentrating on the creation of cutting-edge products, such as implementing AI-driven solutions for kidney biopsy analysis, in an effort to enhance diagnostic accuracy, simplify processes and improve patient outcomes. A solution powered by AI for analysing kidney biopsies is a technology-centric utility that capitalizes on machine learning algorithms and computer vision to assist pathologists and nephrologists in assessing kidney tissue samples. These solutions have been developed with the goal of improving the quality, operational effectiveness, and diagnosing consistency of kidney diseases as well as the evaluation of kidney health. For example, in March 2024, Aiosyn, a software firm based in Netherlands, introduced the NephroPath platform, an innovative AI-powered solution for kidney biopsy analysis. The NephroPath platform employs computational pathology algorithms to examine histological biomarkers in kidney biopsies, which includes recognizing tissue types, gauging interstitial fibrosis, and accurately counting and assessing glomeruli. This AI-facilitated analysis ensures reliable, thorough, and reproducible scoring of renal pathology biomarkers, overcoming the limitations of conventional scoring methods and individual subjectivity.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/renal-cell-carcinoma-global-market-report
Which Is The Largest Region In The Renal Cell Carcinoma Market?
North America was the largest region in the renal cell carcinoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the renal cell carcinoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Renal Cell Carcinoma Market?
2. What is the CAGR expected in the Renal Cell Carcinoma Market?
3. What Are the Key Innovations Transforming the Renal Cell Carcinoma Industry?
4. Which Region Is Leading the Renal Cell Carcinoma Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of The Growing Geriatric Population On Healthcare Demands: A Significant Driver Propelling The Renal Cell Carcinoma Market In 2025 here
News-ID: 4069469 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
